Study in Patients With Knee Osteoarthritis Treated by Embolization Using NBGM200

ConditionKnee Osteoarthritis (Knee OA)

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age50+

SponsorNext Biomedical Co., Ltd.

About this trial

Study in patients with knee osteoarthritis treated by embolization using NBGM200

Eligibility criteria

Qualifiers

Osteoarthritis proven by MR-imaging

Disqualifiers

Current local infection

Life expectancy less than 6 months

Trial design

Treatments tested in this trial

embolization therapy

Treatment groups

72 Participants

are divided into 1 treatment group

Sponsors and collaborators

Next Biomedical Co., Ltd.

Lead sponsor

Source ClinicalTrials.gov